Global fund on AIDS, tuberculosis, and malaria holds first board meeting

@article{Kapp2002GlobalFO,
  title={Global fund on AIDS, tuberculosis, and malaria holds first board meeting},
  author={C. Kapp},
  journal={The Lancet},
  year={2002},
  volume={359}
}
  • C. Kapp
  • Published 2 February 2002
  • Medicine
  • The Lancet
View on Elsevier
doi.org
6 Citations
Highly Influential Citations
1
Background Citations
1

6 Citations

Citation Type

Citation Type

The past, present and future use of epidemiological intelligence to plan malaria vector control and parasite prevention in Uganda
TLDR
A perspective is provided as to how epidemiological intelligence was used to design malaria control before and during the global malaria eradication programme (GMEP) and to contrast this with the evidence generated in support of the Roll Back Malaria (RBM) initiative from 1998 to date.
Surveillance of tuberculosis.
TLDR
The two major changes currently observed are the move from paper-based registers to individual computerized surveillance databases and the multiplication of indicators for documenting progress towards tuberculosis elimination and there is a risk that implementation of these changes be followed by a loss in data quality.
QTF-Gold assay for monitoring of anti-tuberculosis therapy in subjects with active TB
TLDR
A successful therapy for tuberculosis causes a significant decrease of the ESAT-6 and CFP-10 response and this data suggest that the QTF-Gold assay may have a role as a tool for evaluating tuberculosis eradication after standard tuberculosis treatment.
A catastrophe in the 21st century: the public health situation in South Africa following HIV/AIDS
During the early 1900s, African populations in South Africa were subject to very widespread infections which especially affected the young. This resulted in high mortality rates and a low life…
OVERVIEW OF PUBLIC HEALTH AND LIFE EXPECTANCY IN SOUTH AFRICA
  • 2005
Genome sequence of the human malaria parasite Plasmodium falciparum
TLDR
The genome sequence of P. falciparum clone 3D7 is reported, which is the most (A + T)-rich genome sequenced to date and is being exploited in the search for new drugs and vaccines to fight malaria.